NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

flipper, I think many of us (including management) have long suspected that some of the parties involved with financings over the years were at least partially involved in the manipulation of the stock. It won’t be known who all the responsible entities are, and whether there was any coordination among them until discovery, and even then, it may be difficult to get the whole story, as there will be attempts to disguise their nefarious activities and obfuscation of facts. Northwest Bio has their own record of the relevant financing dates to pin some of it down though.

Other than the reputational damage, loss of institutional investors, analyst coverage, and illiquidity of the stock, another major ramification of de-listing from a national exchange is the reduction in access to capital, both terms of the equity and loans, but also the quality of the lenders. It’s pretty well known that there are a number of shady lenders who prey on small companies on the OTC.